Bracken

When launching a product or service, it all comes down to one essential question: what problem are you really trying to solve?    In this SNiP, global marketing strategist and life science industry expert Mary Costello breaks down the essential steps to uncovering the root causes of a company’s marketing challenges. From the importance of understanding buyer behavior to the consequences of burning through time and money without validating demand, Mary shares the realities of marketing that every life science startup, large-scale company, and clinical research organization must face.    With practical advice on avoiding costly mistakes and insight into aligning your strategy with customer needs, Mary’s approach is as actionable as it is insightful—and she delivers it in under 8 minutes.     Tune in now, and subscribe to Fractals to be the first to hear Mary’s upcoming full-length episode: https://lnkd.in/e8W7ckqp   #FractalsSNiPs #FractalsLifeScienceConversations #MarketingStrategy #LifeSciences #ClinicalResearch #BusinessDevelopment #LifeSci 

In the biopharmaceutical industry, groundbreaking discoveries may start in the lab—but to reach the market, they require more than just great science. In this SNiP, life sciences veteran Dr. Graham Lumsden highlights an essential yet often overlooked step: identifying unmet medical needs before developing a solution. Drawing from decades of experience, Graham shares the value and necessity of a market-first approach, where science and business strategy align to drive commercial success. Especially relevant for researchers and investors seeking to bridge the gap between discovery and market adoption, Graham discusses the importance of anticipating customer needs and ensuring a clear path to profitability—a critical foundation that turns innovative research into impactful, sustainable products. Tune in for Graham’s practical approach and subscribe to Fractals on your favorite podcast platform to be the first to hear the full conversation: https://lnkd.in/eMXRtej8 #SNiPsFractalsLifeScienceConversations #FractalsLifeScienceConversations #ProductDevelopment #MarketAnalysis #Commercialization #Investment #LifeSci #Bracken

Biotech appears to be entering its optimistic era driven by a spike in biotech mergers, acquisitions and IPOs—collectively referred to as “exits”. Find out what industry experts have to say about these latest developments: https://hubs.la/Q02W6CYP0 #Biotech #IPOs

The Boston Imaging Round Table is tomorrow—Bracken CEO and medical imaging expert Colin Miller, PhD, FIPEM, CSci, will be in attendance. Meet Colin and learn more about Bracken’s wider imaging team here: https://lnkd.in/eNYhT_ft #MedicalImaging #ClinicalTrials #Imaging #LifeSci #Bracken

A well-researched scientific product + a market-first approach = a well-mapped route to success. In tomorrow's SNiP, Dr Graham Lumsden examines a crucial—and frequently overlooked—step: beginning with the unmet demands of the market. Whether you're an investor or a researcher, Graham's thoughts on bridging the gap between commercial viability and discovery show how important it is to predict client demands in order to develop products that have an impact and last. Subscribe to Fractals today to ensure you never miss an episode: https://lnkd.in/gtfzdwSx #SNiPsFractalsLifeScienceConversations #FractalsLifeScienceConversations #MarketResearch #ProductDevelopment #Investment #CommercialSuccess #LifeSci #Bracken

#MedidataNEXT starts today! Will you be in attendance? Connect with Bracken Senior Partner Paul Martinetti, MD and discuss the future of clinical trial imaging, new digital health approaches, or transformative strategies in life sciences. Looking forward to seeing you there! #ClinicalTrials #DigitalHealth #LifeSci #Bracken

The FDA will begin to phase out the Rare Pediatric Disease Priority Review Voucher (PRV) program after December 20, 2024. The agency will no longer award PRVs unless the product has been designated as a rare pediatric disease drug by then and received FDA approval by September 30, 2026. Here are some key points from the update and important reminders from the 2019 FDA draft guidance: https://hubs.la/Q02W6wJH0 #FDA #Compliance

Bracken is pleased to announce that our CEO and medical imaging expert, Colin Miller, PhD, FIPEM, CSci, will attend the Boston Imaging Round Table on November 14th! Learn more about Colin and Bracken's wider medical imaging team here: https://lnkd.in/eNYhT_ft #BostonImagingRoundTable #MedicalImaging #ClinicalTrials #LifeSci #Bracken

Are you heading to #MedidataNEXT this week? Don’t miss a chance to connect with Paul Martinetti, MD, Senior Partner at Bracken. Join him in NYC on November 13-14 to discuss the future of clinical trial innovation, digital health, and imaging support. #ClinicalTrials #DigitalHealth #LifeSci #Bracken

Bridging the gap in clinical trials—Bracken Senior Partner Deepak Behera, MD will discuss how community practices can provide advanced care in nuclear medicine during tomorrow's presentation at the 2024 ATAWM and CCSNMMI Michigan Road Show. Learn more about working with Dr. Behera and Bracken's full range of radiopharmaceutical expertise and services here: https://lnkd.in/e_q2C4Ci #Radiopharmaceuticals #NuclearMedicine #ClinicalTrials #PatientCare #LifeSci #Bracken